# FDA 483 - Department of Defense - Navy - October 03, 2024

Source: https://www.globalkeysolutions.net/records/483/department-of-defense-navy/65a8db81-f81a-4563-8d98-4e4daed1fc1f

> FDA 483 for Department of Defense - Navy on October 03, 2024. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Department of Defense - Navy
- Inspection Date: 2024-10-03
- Product Type: biologics
- Office Name: Baltimore District Office
- Summary: The Department of Defense - Navy, a blood bank/donor center in Bethesda, MD, was cited for significant deficiencies during an FDA inspection. Observations included the use and distribution of blood products processed with unapproved centrifuges, and failures to timely notify consignees of further testing results for HCV and HIV. Additionally, donor physical examinations were not adequately performed during blood drives.

## Related Officers

- [La-tasha M. Gunter](https://www.globalkeysolutions.net/people/la-tasha-m-gunter/db9cd9cf-db0a-4c31-9f7c-24760750f34d)

Company: https://www.globalkeysolutions.net/companies/department-of-defense-navy/3bd0b93e-7977-4b26-ba2c-2f9688483f20

Office: https://www.globalkeysolutions.net/offices/baltimore-district-office/6be371ff-03e9-4039-999c-ff170f17a9fa